By DBA, we identified intragenic breakpoints disrupting EWSR1 in Ewing sarcoma (ES6, EW12, EW22), neuroblastoma (GOTO, NBsusSR), and melanoma (CHL-1, SH4) (Figure 5A and Table S2). Here, EWSR1 is linked to melanoma.